| Grerk Sutamtewagul, MD | |
|
200 Hawkins Dr, Dept Of Internal Medicine, Iowa City, IA 52242-1009 | |
| (319) 356-1616 | |
| (319) 353-8383 |
| Full Name | Grerk Sutamtewagul |
|---|---|
| Gender | Male |
| Speciality | Hematology |
| Experience | 16 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003103383 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Great River Medical Center | West burlington, IA | Hospital |
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
The dream of suspended animation has long captivated the human imagination, reflected in countless works of mythology and fiction, from King Arthur and Sleeping Beauty to Captain America and Han Solo.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
A new slow-release vaccine has been shown to boost the immune system's response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.
Men in their thirties who had inflamed gums caused by severe periodontal disease were three times more likely to suffer from erection problems, according to a study published in the Journal of Sexual Medicine.
The Telegraph looks at the upcoming Mobile Health Africa Summit, the first event of its kind where stakeholders across Africa and the world will come together to debate the implementation of m-health across the continent.
› Verified 8 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
The dream of suspended animation has long captivated the human imagination, reflected in countless works of mythology and fiction, from King Arthur and Sleeping Beauty to Captain America and Han Solo.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
A new slow-release vaccine has been shown to boost the immune system's response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.
Men in their thirties who had inflamed gums caused by severe periodontal disease were three times more likely to suffer from erection problems, according to a study published in the Journal of Sexual Medicine.
The Telegraph looks at the upcoming Mobile Health Africa Summit, the first event of its kind where stakeholders across Africa and the world will come together to debate the implementation of m-health across the continent.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grerk Sutamtewagul, MD 200 Hawkins Dr, C32gh, Iowa City, IA 52242-1009 Ph: (319) 356-1616 | Grerk Sutamtewagul, MD 200 Hawkins Dr, Dept Of Internal Medicine, Iowa City, IA 52242-1009 Ph: (319) 356-1616 |
News Archive
The dream of suspended animation has long captivated the human imagination, reflected in countless works of mythology and fiction, from King Arthur and Sleeping Beauty to Captain America and Han Solo.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
A new slow-release vaccine has been shown to boost the immune system's response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.
Men in their thirties who had inflamed gums caused by severe periodontal disease were three times more likely to suffer from erection problems, according to a study published in the Journal of Sexual Medicine.
The Telegraph looks at the upcoming Mobile Health Africa Summit, the first event of its kind where stakeholders across Africa and the world will come together to debate the implementation of m-health across the continent.
› Verified 8 days ago
Rami G. El Abiad, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4901 Fax: 319-384-8559 | |
Dr. Kaleb Tanner Veit, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Drive, Iowa City, IA 52242 Phone: 319-353-6239 Fax: 319-353-6406 | |
Dr. Elizabeth R Bowen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Department Of Internal Medicine, Iowa City, IA 52242 Phone: 319-353-7842 Fax: 319-353-7850 | |
Balarama Krishna Surapaneni, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4019 Fax: 319-353-8073 | |
Soorih Shaikh, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2148 Fax: 319-353-8383 | |
Dr. Richard Ellis Larew, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2460 Towncrest Dr, Iowa City, IA 52240 Phone: 319-338-7862 |